National Eye Institute

In June, the House Energy and Commerce Committee published recommendations to reform the NIH, including consolidating the National Eye Institute into a Neurological Science and Brain Institute.

The link between nutrition and ocular health became apparent in the early 1990s as epidemiologists and ophthalmologists uncovered dietary patterns in patients with AMD.

Over the next 5 years, the National Eye Institute is aiming to eliminate vision loss and improve quality of life through vision research, according to a press release from the organization.

The National Eye Institute has joined several ophthalmic organizations in calling for the standardization of data formatting in ophthalmic imaging devices, according to a press release.

LumiThera Inc. is the recipient of a $1.5 million grant from the National Eye Institute in support of a clinical trial investigating a new treatment for diabetes-related ocular pathology, according to a press release.

Since its inception in 2002, the Diabetic Retinopathy Clinical Research Network has initiated more than 30 clinical studies for the management and evaluation of diabetic retinopathy. In 2018, the network expanded its scope to include research of other retinal disorders, and in 2019, officially changed its name from DRCR.net to the DRCR Retina Network. The network has since opened its research doors to all retinal pathologies, an exciting prospect for network representatives, ophthalmic researchers and clinicians.

Aptly published in the Dry Eye Awareness Month of July was the long-awaited Tear Film and Ocular Surface Society Dry Eye Workshop II report. Ten years have passed since the TFOS DEWS I report was published, and this new iteration discloses the results of years of intensive work by 150 experts from 23 countries, working in 12 subcommittees, who considered the wide-ranging, multiple aspects of dry eye disease.

NEW ORLEANS — The risk for diabetic retinopathy is cut in half in people with type 2 diabetes who intensively control their blood glucose, according to results from the ACCORDION study.

LAS VEGAS — OCT is increasingly useful in diagnosing disorders that affect optical pathways to the brain, a speaker told colleagues.